Management

SAMSUNG C&T CORPORATION Fashion Division’s Second-Quarter Operating Profit Jumps 60%

Strong Consumer Sentiment Drives Revenue Growth

KYUNG GYEYOUNG
2026-07-29 15:54:07
[Edaily Reporter KYUNG GYEYOUNG ] SAMSUNG C&T CORPORATION(028260) ’s fashion division announced on the 29th that its second-quarter operating profit reached 54 billion won, a 63.6% increase compared to the same period last year.

Preliminary figures show that revenue for the same period rose 16.3% to 593 billion won. The operating profit margin stood at 9.1%, up 2.6 percentage points from 6.5% in the second quarter of last year.

SAMSUNG C&T CORPORATION attributed the significant improvement in profitability to stricter management of discount rates. With consumer sentiment remaining strong, the company’s core in-house and imported brands grew evenly, sustaining the upward trend in revenue.

SAMSUNG C&T CORPORATION explained that while the business environment may become challenging in the second half of the year due to concerns over a decline in consumer sentiment, it will strive to achieve annual revenue growth and improved profitability by strengthening the competitiveness of its products and brands.

A view of the Alaïa store inside the Galleria Luxury Mall, exclusively distributed in Korea by “10 Corso Como Seoul,” the concept store of SAMSUNG C&T CORPORATION’s Fashion Division. (Photo: SAMSUNG C&T CORPORATION)

Economy

Corporation

IT·Science

Economy

"AI Broadcasts on Its Own"... A Creator Startup Founded by a Former TikTok Employee [VC Cradle]

A virtual creator that doesn’t require a human actor has emerged. There is no pre-written script, nor is there an operator manipulating it in real time. Artificial intelligence (AI) hosts the broadcas…
2026-08-08 11:01:04

Corporation

Mezzion Pharma Co., Ltd. Simultaneously Improves Cysts and Kidney Function in ADPKD… “Moving Directly to Phase 2b Clinical Trials in Korea and the U.S.”

“When you examine the kidneys of mice with polycystic kidney disease, you can see large cysts. However, after administering Udenafil, a reduction in the size of these cysts was visible even to the nak…
2026-08-08 08:16:01

IT·Science

SK BIOPHARMACEUTICALS Soars on Cenobamate Growth… The Era of 45% Generic Drug Prices Begins [Weekly Bio Roundup]

(Graphic: Generative AI) During the first week of August (August 3–7), SK BIOPHARMACEUTICALS posted its best-ever quarterly earnings, driven by the growth of its new epilepsy drug “cenobamate.” Ad…
2026-08-08 08:31:03